The research on the pharmacodynamic and pharmacokinetic of low-dose ticagrelor in healthy Chinese population

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15006505

Enrollment

Unknown

Registered

2015-06-04

Start date

2015-07-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cornary Heart Disease

Interventions

standard dose of ticagrelor:90mg bid

low dose of ticagrelor:45mg bid

standard dose of clopidogrel:75mg qd

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Healthy adult age 18-45 years old; Voluntary clinical trials, And signed informed consent.

Exclusion criteria

Exclusion criteria: 1. contraindication to antiplatelet therapy; 2. haemoglobin 2 times the upper normal limit; 6. chronic renal failure (creatinine clearance<30 mL/min); and 7. active peptic ulceration or gastrointestinal bleeding.

Design outcomes

Primary

Measure	Time frame
PRU;	—

Countries

China

Contacts

Public ContactLiping Ma

mlp-125@163.com+86 15921008819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026